Abhishek Nikhil Shah

Abhishek Nikhil Shah

Active Director Director DIN 00338653
DIN 00338653 First appointment Dec 2002 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Dec 2002
Shareholding value •••• Premium profile

About Abhishek Nikhil Shah

Data last updated:

Abhishek Nikhil Shah is a Director at Marvel Drugs Pvt Ltd (since 2002) and Director at Wellthy Therapeutics Private Limited (since 2015). The companies operate in Pharma, Internet and Agriculture. The 2 current companies with reported revenue have a combined latest revenue of ₹18.38 Cr; the largest is Marvel Drugs Pvt Ltd at ₹11.53 Cr (FY 2025). Earlier, Abhishek Nikhil Shah was a Director at M.I.T.R.A. Agro Equipments Private Limited (2012–2014) and Director at Catalog Educational Services Private Limited (2012–2014) and 3 more.

DIN 00338653
Primary Designation Director
Industry Pharma
First Appointment 19 Dec 2002
Oldest Company Age 40 yrs
Largest company Marvel Drugs Pvt Ltd · ₹11.53 Cr (FY 2025)
Combined revenue ₹18.38 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Marvel Drugs Pvt Ltd U24230MH1986PTC039868
Director19 Dec 20021986₹11.53 Cr (FY 2025)Active
Wellthy Therapeutics Private Limited U93030MH2015PTC270628
Director02 Dec 20152015₹6.84 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Oct 20122012₹64.20 Cr (FY 2025)Active
Director31 Oct 20122009₹1.92 Cr (FY 2025)Active
Ekstop Shop Private Limited U74120MH2012PTC226144
Additional Director30 Dec 20132012Active
Joule Consulting Private Limited U74120MH2011PTC212101
Nominee Director10 Aug 20122011₹7.17 Cr (FY 2025)Active
Haraka Food Private Limited U74120MH2013PTC243931
Nominee Director02 Jul 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Abhishek Nikhil Shah

Directorship timeline

Open interactive timeline →
Marvel Drugs Pvt Ltd
Haraka Food Private Limited
Wellthy Therapeutics Private Limited
M.I.T.R.A. Agro Equipments Private Limited
Premium access

Shareholding and investment profile for Abhishek Nikhil Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Nikhil Shah

Abhishek Nikhil Shah currently holds 2 directorships: Marvel Drugs Pvt Ltd (Director, since 19 Dec 2002, revenue ₹11.53 Cr (FY 2025)); Wellthy Therapeutics Private Limited (Director, since 02 Dec 2015, revenue ₹6.84 Cr (FY 2025)).

Abhishek Nikhil Shah was first appointed on 19 Dec 2002 as Director at Marvel Drugs Pvt Ltd. The most recent appointment on record is 02 Dec 2015 at Wellthy Therapeutics Private Limited.

The 2 current companies of Abhishek Nikhil Shah that report revenue have a combined latest revenue of ₹18.38 Cr: Marvel Drugs Pvt Ltd ₹11.53 Cr (FY 2025); Wellthy Therapeutics Private Limited ₹6.84 Cr (FY 2025).

Abhishek Nikhil Shah held 5 earlier board appointments: M.I.T.R.A. Agro Equipments Private Limited (Director, 09 Oct 2012 to 18 Feb 2014); Catalog Educational Services Private Limited (Director, 31 Oct 2012 to 11 Nov 2014); Ekstop Shop Private Limited (Additional Director, 30 Dec 2013 to 02 Sep 2014); Joule Consulting Private Limited (Nominee Director, 10 Aug 2012 to 03 Sep 2014); Haraka Food Private Limited (Nominee Director, from 02 Jul 2013).

The current boards of Abhishek Nikhil Shah's companies include Nikhil Jitendra Shah (Marvel Drugs Pvt Ltd), Amit Chhajer (Wellthy Therapeutics Private Limited), Prayat Aasit Shah (Wellthy Therapeutics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available